According to a new market report published by Lucintel, the future of artificial intelligence (AI) in the cancer market looks promising with opportunities in the diagnosis, therapy, prognosis, health management, research applications. The opportunities for artificial intelligence in the global cancer market are- expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer and rising research and development activities related to its treatment.
In this market, surgery & chemotherapy, radiotherapy, immunotherapy, alteration of tumor microenvironment, phototherapy, theranostics, gene therapy, hyperthermia therapy, and sonodynamic therapy are the major therapies. Lucintel forecasts that surgery and chemotherapy will remain the largest therapy segment over the forecast period due to increasing prevalence of cancer and growing healthcare insurance & its reimbursement.
North America will remain the largest region over the forecast period due to increasing research and development activities related to cancer treatment and presence of developed healthcare infrastructure.
IBM, Digital Reasoning, Intel, Microsoft, Cancer Center.ai, Nvdia, Niramai Health Analytix, Johnson & Johnson, GE Healthcare, and Varian Medical Systems are among the major suppliers of artificial intelligence in the global cancer market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities for artificial intelligence in the global cancer market by AI tool, therapy, algorithm type, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Artificial Intelligence in Cancer Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for artificial intelligence in the global cancer market by AI tool, therapy, algorithm type, application, and region as follows:
By AI Tool [Value ($ Million) shipment analysis for 2014 – 2025]:
Machine Learning
Natural Language Processing
Image Processing
Speech Recognition
By Therapy [Value ($ Million) shipment analysis for 2014 – 2025]:
Surgery & Chemotherapy
Radiotherapy
Immunotherapy
Alteration of Tumor Microenvironment
Phototherapy
Theranostics
Gene Therapy
Hyperthermia Therapy
Sonodynamic Therapy
By Algorithm Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Artificial Neural Networks
Deep Learning
Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.